At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LABU Direxion Daily S&P Biotech Bull 3x Shares
Post-Mkt 07-20 19:19:41 EDT
249.10
-16.46
-6.20%
盘后250.60
+1.50+0.60%
19:16 EDT
High277.07Low248.57Vol293.34K
Open268.00D1 Closing265.56Amplitude10.73%
Mkt Cap566.57MTradable Cap566.57MTotal Shares2.27M
T/O76.60MT/O Rate12.90%Tradable Shares2.27M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.
TIPRANKS  ·  33 minutes ago
AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.
Healthcare Shares Lose Ground
Dow Jones  ·  04:52
Healthcare Shares Lose Ground
Health Care Roundup: Market Talk
Dow Jones  ·  04:50
Health Care Roundup: Market Talk
Healthcare Triangle Shareholders Approve Key Governance Measures
TIPRANKS  ·  04:32
Healthcare Triangle Shareholders Approve Key Governance Measures
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
Dow Jones  ·  03:17
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
Sector Update: Healthcare
MT Newswires Live  ·  03:06
Sector Update: Healthcare
3 Australian Penny Stocks With Strong Balance Sheets Worth A Closer Look
Simply Wall St.  ·  02:34
3 Australian Penny Stocks With Strong Balance Sheets Worth A Closer Look
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
Dow Jones  ·  01:26
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
Sector Update: Healthcare
MT Newswires Live  ·  01:10
Sector Update: Healthcare
Health Care Roundup: Market Talk
Dow Jones  ·  00:20
Health Care Roundup: Market Talk
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Personalis (PSNL) and PTC Therapeutics (PTCT)
TIPRANKS  ·  07-20 23:50
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Personalis (PSNL) and PTC Therapeutics (PTCT)
Pharvaris (PHVS) Could Be 92% Undervalued On FDA NDA Acceptance
Simply Wall St.  ·  07-20 23:25
Pharvaris (PHVS) Could Be 92% Undervalued On FDA NDA Acceptance
FDA Maintains Link Between Taylor Farms Lettuce and Cyclospora Outbreak Despite Retracting Test Result
Deep News  ·  07-20 23:21
FDA Maintains Link Between Taylor Farms Lettuce and Cyclospora Outbreak Despite Retracting Test Result
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
Dow Jones  ·  07-20 23:17
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
Red Violet's Forewarn Expands Into Home Healthcare
MT Newswires Live  ·  07-20 22:24
Red Violet's Forewarn Expands Into Home Healthcare
Will Tinlarebant’s First-in-Disease Data and FDA Filing Change Belite Bio’s (BLTE) Narrative?
Simply Wall St.  ·  07-20 21:20
Will Tinlarebant’s First-in-Disease Data and FDA Filing Change Belite Bio’s (BLTE) Narrative?
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Foghorn Therapeutics (FHTX)
TIPRANKS  ·  07-20 21:10
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Foghorn Therapeutics (FHTX)
Acadia Pharmaceuticals receives FDA Fast Track designation for remlifanserin
TIPRANKS  ·  07-20 21:10
Acadia Pharmaceuticals receives FDA Fast Track designation for remlifanserin
Sector Update: Healthcare
MT Newswires Live  ·  07-20 21:00
Sector Update: Healthcare
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
GlobeNewswire  ·  07-20 21:00
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
No data available

Introduction

Company Name.
Direxion Daily S&P Biotech Bull 3x Shares
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Issue price:
--